MedTrace Logo

Ancillary T Cell Based Studies in SPIROMICS

NCT02036190 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 175

Last updated 2016-06-03

No results posted yet for this study

Summary

The long-term objectives of this ancillary application are to characterize a subpopulation of smokers with auto-reactive T cell response, to validate immunodiagnostic assays that could detect emphysema, and to find molecular signatures for pathogenic T cell development in a well-characterized cohort participating in SPIROMICS (UCSF center).

Conditions

  • Smoke Induced Lung Disease

Sponsors & Collaborators

Principal Investigators

  • Laura Koth, MD · University of California, San Francisco

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2016-01-31
Completion
2016-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02036190 on ClinicalTrials.gov